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Background:  Basilar artery occlusion (BAO) leads to high rates of morbidity and mortality, despite 
successful recanalization.  The discordance between flow restoration and long-term functional status 
clouds clinical decision making regarding further aggressive care.  We sought to develop and validate a 
practical, prognostic tool for the prediction of 3-month favorable outcome after acute reperfusion 
therapy for BAO.   
Methods:  This retrospective, multicenter, observational study was conducted at four high-volume 
stroke centers in the U.S. and Europe.  Multivariate regression analysis was performed to identify 
predictors of favorable outcome (90-day mRS scores 0–2) and derive a clinically applicable prognostic 
model (the Pittsburgh Outcomes after Stroke Thrombectomy-VertebroBasilar (POST-VB) score).  The 
POST-VB score was evaluated and internally validated apropos of calibration and discriminatory ability.  
External validity was assessed in patient cohorts at 3 separate centers. 
Results:  In the derivation cohort of 59 patients, independent predictors of favorable outcome included 
smaller brainstem infarct volume on post-procedure MRI (p<0.01) and younger age (p=0.01). The POST-
VB score was calculated as: age + (10 × brainstem infarct volume). The POST-VB score demonstrated 
excellent discriminatory ability (AUC=0.91) and adequate calibration (p=0.88) in the derivation cohort 
(center A).  POST-VB performed equally well across the 3 external validation cohorts (center B, 
AUC=0.89; center C, AUC=0.78; center D, AUC=0.80).  Overall, a POST-VB score <49 was associated with 
an 88% likelihood of favorable outcome, as compared to 4% with a score ≥125.   
Conclusions:  The POST-VB score effectively predicts 3-month functional outcome following acute 
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INTRODUCTION 
Basilar artery occlusion (BAO) may result in devastating ischemia of critical anatomic structures within 
the brainstem and cerebellum, and if left untreated is associated with a dismal prognosis and high 
mortality (≥90%).(1,2) Recently concluded randomized controlled trials, the BEST and the BASICS trial, 
did not demonstrate a benefit of endovascular thrombectomy (EVT) over best medical management for 
acute  basilar artery occlusion (BAO) strokes.(1)  Retrospective data suggests that endovascular 
recanalization for the treatment of BAO maybe safe and effective, with successful reperfusion being 
achieved in 81-92% of patients.(3,4)  Intravenous thrombolytic therapy (IVT) has led to at least as good 
outcomes as the endovascular approach.(5,6) Despite the high rate of recanalization with endovascular 
treatment, the majority of patients intervened upon still experience poor outcomes (90-day mRS ≥3 in 
55 - 68%).(3,4,7,8) 
 
With increasing adoption of aggressive interventions for BAO, studies have sought to elucidate the 
potential capabilities of pre-procedural characteristics to predict functional outcome and aid in the 
selection of patients most likely to benefit from recanalization.(9–11)  Although the prognostic value of 
overall infarct volume is well established in anterior circulation stroke, initial analyses evaluating BAO 
did not find similar correlations with posterior circulation lesions.(12)   However, recent trials 
incorporating pathoanatomic scoring of posterior circulation infarction have demonstrated improved 
correlation with functional outcome after BAO.(9,12,13)  Nevertheless, even in highly selected analyses 
(i.e. those excluding patients with extensive brainstem ischemic changes) favorable outcomes following 
successful recanalization may still only be observed in 49% of BAO patients.(3) Conversely, utilizing 
overly selective pre-procedural criteria may increase the risk of withholding therapy from patients with a 
smaller yet clinically important potential for benefit. 
 
Early and prolonged invasive supportive measures are frequently necessary in patients destined for 
good outcomes, thus forcing decisions regarding aggressiveness of care to be made in the immediate 
post-procedure period.  Incongruent rates between successful recanalization and good clinical outcome 
necessitates accurate prognostic tools to better discriminate between those patients who will benefit 
from early and aggressive supportive measures and those who should be considered for de-escalation of 
care.  No study has yet assessed and/or externally validated post-procedural characteristics as a means 
of better predicting the functional outcome of those who have undergone acute reperfusion therapy of 
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recanalization therapy. Not too infrequently, this results in still critically ill patients with unequivocal 
prognosis, in whom post procedure phase requires careful weighing of optimal care, i.e. continuation of 
aggressive measures or rather de-escalation of advanced care. A prognostic score, with the ability to 
predict functional outcome at 3 months based on post procedure information, may be an important tool 
to support decision making for a longer-term therapy plan. 
The purpose of this study was to develop, evaluate, and externally validate the utility of a post-
procedural scoring system for the prediction of functional outcome after acute reperfusion therapy of 
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METHODS 
Patient Population 
This retrospective, multicenter, observational study was conducted at four high-volume stroke centers 
in the USA (Pittsburgh-Center A, Atlanta-Center B), Germany (Dresden-Center C), and Finland (Helsinki-
Center D) with IRB (University of Pittsburgh Ethics Board) or local ethics committee approval.  Informed 
consent was not required due retrospective analysis of the data).  The data used for this study are 
available from the corresponding author upon reasonable request.  The overall study sample was 
created by retrospectively identifying all consecutive patients with radiographically confirmed acute 
symptomatic BAO between July 2000 to July 2012.  Patients were included for analysis if presenting 
neurologic symptomatology was referable to BAO as demonstrated on conventional catheter-based 
digital subtraction angiography (DSA) or MR/CT angiography, and followed by post-procedural MR 
imaging.  BAO was defined as complete absence of anterograde flow in the basilar artery despite 
delayed filming.  Patients were excluded from analysis if clinical or radiographic data were missing or 
incomplete.  Baseline demographic information, clinical characteristics at presentation, and clinical 
course were all prospectively recorded.   
 
Patient Selection and Treatment 
In accordance with current guidelines intravenous recombinant tissue plasminogen activator (IV tPA) 
was administered to eligible patients.  Patients were deemed to be candidates for endovascular therapy 
per local institutional protocols, broadly following criteria: 1) clinical symptoms referable to posterior 
circulation ischemia, and 2) pre-treatment imaging without evidence of intracranial hemorrhage and/or 
extensive infarction that precluded a meaningful recovery in the opinion of the treating stroke 
neurologist (i.e. entirety of the pons or bilateral thalami).  The decision to proceed with endovascular 
treatment was made between the stroke neurologist and neuro-interventionalist. The endovascular 
reperfusion techniques utilized included intra-arterial pharmacologic thrombolysis and/or mechanical 
thrombectomy.  The technical approach was left to the discretion of the treating neuro-




Baseline demographics, clinical stroke severity, procedural characteristics, angiographic reperfusion 
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variables.  Clinical stroke severity was measured by NIHSS score.  Reperfusion status was assessed on 
final angiographic runs according to the modified Thrombolysis in Cerebral Infarction (mTICI) scale; 
successful recanalization was defined as mTICI grade 2b or 3.(16)  Final infarct burden was determined 
by post-procedural MRI that was performed within 24-hours of the procedure.  MRI was performed on 
1.5 or 3 Tesla scanners according to institutional protocols.  At a minimum, all centers performed these 
sequences: 1) T2-weighted gradient-echo, 2) diffusion-weighted imaging with apparent diffusion 
coefficient map reconstruction; and 3) fluid-attenuated inversion recovery.  Sectorial volumetric analysis 
of post-procedure infarct burden assessed the following anatomic regions irrigated by the posterior 
circulation: each thalamus, each occipital lobe, brainstem (midbrain, pons and medulla), and cerebellum 
[Figure 1]. At Center A, C and D, the infarct volume for each anatomic sector was calculated by outlining 
the DWI lesion perimeter with a graphing tool available on the Siemens workstation to determine infarct 
area on each axial slice. At center B, area measurement for each slice was performed manually 
(previously proven to have high correlation with Siemens graphing tool).(17) The product of the slice 
thickness and the summation of infarct areas gave the infarct volume for each anatomic sector.  
 
Outcomes 
The primary outcome was the degree of functional recovery at 3-month follow-up visit as determined by 
a trained, unblinded stroke neurologist according to the modified Rankin Scale (mRS), and was recorded 
prospectively.  Favorable functional recovery was defined as a mRS of 0 to 2. 
 
Statistical Analysis 
Acceptable Type I error was set a priori at α=0.05 for all statistical tests.  All analyses were defined a 
priori.  Patients with missing and/or incomplete clinical, radiographic, or outcome data were excluded 
from analyses.  Continuous demographic characteristics were assessed for normality using the 
Kolmogorov-Smirnov test; normally distributed data were analyzed by t-test while the remainders were 
compared using the Wilcoxon Rank-Sum test.  Categorical data were analyzed by Pearson’s chi-squared 
or Fisher’s exact test. 
 
Initial univariable and multivariate analysis and predictive model derivation was performed utilizing the 
UPMC (center A) cohort. Univariable regression analysis was performed to assess the association 
between predictive variables and 3-month favorable functional outcome.  Multivariable regression 
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adjustment, variables that did not reach significance at the α=0.10 level were excluded.  A scoring 
system for the prediction of functional outcome (the Pittsburgh Outcomes after Stroke Thrombectomy 
VertebroBasilar (POST-VB)) was developed based on β-coefficients of each specific predictive variable 
from the fitted multivariate logistic regression model.  
 
We assessed the performance of the POST-VB apropos of accuracy, discrimination, and calibration.  
Accuracy was assessed through calculation of the average prediction error, or Brier score; ideally scores 
should be < 0.25 (better than flip of a coin).  Discrimination was assessed using the area under the 
receiver operating characteristic curve (AUC).  Using current statistical consensus, AUC of 0.8 to 0.9 are 
considered very good, 0.7 to 0.8 as adequate, and below 0.7 as poor.(18)  Calibration is the 
measurement of agreement between predicted and observed risk over the full range of predicted 
probabilities, and was tested with the Hosmer-Lemeshow goodness-of-fit test. To perform this test 
patients were grouped by POST-VB score into 5 levels and significant deviation was set a priori at  
0.05.  The evaluation of predictive performance using patients from the original derivation sample may 
result in an overly optimistic estimate of predictive performance, therefore a 10-fold cross validation for 
the AUC was applied.(19)  Clinical utility was evaluated by decision curve analysis.(20,21)  
 
External validity of the POST-VB scoring system was assessed in separate cohorts of patients suffering 
BAO undergoing acute reperfusion therapy at 3 high-volume stroke centers (Atlanta, Dresden, and 
Helsinki); these retrospective analyses were performed on the prospectively collected data from each 
site.  Predictive performance of the POST-VB score applied to all external cohorts was similarly assessed 
apropos of discrimination and calibration as described above.  
 
Means are reported as mean ± standard deviation; significant associations between outcomes and 
predictors are reported as odds ratios (OR) with 95% confidence intervals (CI).  Data were analyzed using 
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RESULTS 
Baseline demographics and clinical characteristics for the 59 patients analyzed in the derivation cohort 
(patients from center A) are displayed in Table 1.  The mean age was 64 ± 13 years; 34% of this cohort 
were female.  The median NIHSS on presentation was 18 (IQR 22), and 48% presented with an NIHSS 
≥20.   
 
Twelve-percent of the patients presenting to center A met criteria for and subsequently received IV tPA.  
Median time from symptom onset to initiation of endovascular treatment was 13 hours (IQR 35).  
Endovascular techniques utilized for recanalization (either alone or in combination) included intra-
arterial pharmacologic thrombolysis (42%), mechanical thrombectomy (including MERCI retriever, 
stentriever, or manual aspiration), and/or angioplasty with/without stenting; proportions of individual 
techniques are displayed in Table 1.  Successful reperfusion (mTICI 2b-3) was achieved in 90% of cases. 
 
Figure 2 displays mean final infarct volumes by anatomic region, as demonstrated on post-procedural 
MRI.  Thirty-seven percent of patients had evidence of infarction in all anatomic regions assessed.  
Overall, the median total infarct volume was 26 mL (IQR 46, range 0-295).   
 
Outcomes and Predictive Model Derivation 
Overall, 56% of patients survived beyond 3 months.  Thirty-two percent of the entire cohort achieved 
functional independence (mRS 0-2).  Figure S1 depicts a breakdown of the derivation cohort by 3-month 
mRS.  Baseline demographics, clinical characteristics, procedural factors, and post-procedural imaging 
findings were assessed for association with 3-month functional outcome utilizing univariable logistic 
regression.  The factors significantly independently associated with 3-month functional independence 
included smaller infarct volumes within the brainstem (OR 2.02; 95% CI 1.35-3.01) and cerebellum (OR 
1.04; 95%CI 1.01-1.07).  Stepwise, multivariable logistic regression analysis identified younger age and 
smaller brainstem infarct volume as significant independent predictors of 3-month functional 
independence (OR 1.04; 95% 1.01-1.07 and OR 6.57; 95% CI 1.76-24.5, respectively).  The equation for 
the scoring system for the prediction of functional outcome was derived by incorporating the β-
coefficients of these independently significant variables from this multivariable logistic regression model 
(POST-VB score = age + 10 x brainstem infarct volume).   
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The POST-VB score for the prediction of 3-month functional independence displayed adequate accuracy 
(Brier score = 0.15). The ability of the POST-VB scoring system to discriminate between patients 
achieving long-term functional independence versus those being severely disabled or dead, as measured 
by the AUC curve was 0.91 (95%CI 0.84-0.98) indicating excellent discriminatory ability.  The POST-VB 
score displayed effective calibration for predicting functional independence (Hosmer-Lemeshow test, 
p=0.88).  The clinical utility of POST-VB to predict who is most likely to achieve functional independence 
was evaluated through decision curve analysis as an extension of clinical decision-making based on 
history, exam, and hospital course.  Use of the POST-VB score displayed superior net benefit as 
compared to proceeding with aggressive care in all patients beginning at threshold probability (i.e. 
perceived likelihood of functional recovery) of approximately 5% or higher.  This correlated with a net 
reduction of inappropriately pursuing aggressive care in 11 patients likely to be severely disabled or 
dead for every 20 patients at a decision threshold of 50% (i.e. clinicians perceived likelihood of poor 
outcome).  
 
The external validity of POST-VB score to predict 3-month favorable functional outcome was assessed by 
retrospective application to cohorts of patients undergoing endovascular treatment for BAO at 3 
independent, high-volume stroke centers (center B, center C, and center D).  Clinical characteristics used 
in the model were compared between derivation and validation cohorts; brainstem infarct volume (ml) 
was the only significantly different characteristic between cohorts (center A 4.6±4.7 ml, center B 
0.52±0.57 ml, center C 1.3±2.0 ml, and center D 3.1±3.6 ml, p<0.01).  Within each cohort, age and 
brainstem infarct volume remained significant predictors of 3-month functional outcome in both 
univariate and multivariable regression analyses.  Figure 3 displays the receiver operating characteristic 
plot for the POST-VB score applied at each center.  The discriminatory ability of the POST-VB scoring 
system for predicting long-term functional independence ranged from good to very good, with AUCs of 
0.89 for center B, 0.78 for center C, and 0.80 for center D. Rates of mRS 0-2 and mRS 0-3 at 90 days by 
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DISCUSSION 
The POST-VB scoring system is a simple and clinically applicable method able to reliably predict 3-month 
functional outcome following thrombectomy for acute BAO.  This scoring system demonstrated very 
good discriminatory ability as well as external validity when applied to patients treated at a variety of 
high-volume stroke centers (center B, AUC=0.89; center C, AUC=0.78; center D, AUC=0.80).   
 
Although BAO continues to carry a high mortality rate (approximately 30-40%), up to 4 in 10 BAO stroke 
patients may achieve functional independence.  The POST-VB score successfully discriminated between 
those patients who will benefit from early and aggressive supportive measures and those who may be 
considered for de-escalation of care.   Overall, a POST-VB score <49 was associated with an 88% 
likelihood of favorable outcome, as compared to 4% with a score ≥125.  As a practical outcome the 
results of the clinical utility analyses revealed that applying the POST-VB score added significant clinical 
value above that currently offered by routine consideration of individual clinical factors, regardless of a 
treating physician’s certainty of an outcome.  Utilization of the POST-VB score for outcome prediction 
demonstrated a net benefit over standard practice beginning at a perceived certainty threshold 
(perceived likelihood of correctly predicting outcome) from as low as 5% and extending up to 100%. 
Furthermore, decision analysis demonstrated that utilizing the POST-VB score would lead to reduced 
inappropriate utilization of aggressive care in 11 patients likely to be severely disabled or dead for every 
20 patients at a decision threshold of 50% (i.e. physician certainty of outcome equal to flipping a coin). 
 
As of yet there are no randomized controlled trial data supporting the efficacy of thrombectomy for the 
treatment BAO. The Basilar Artery Occlusion Chinese Endovascular Trial (BEST) was neutral and the 
Basilar Artery International Cooperation Study (BASICS) Trial results are eagerly awaited.(1,22)   The 
current American Stroke Association 2019 guidelines offer a class IIb recommendation for 
thrombectomy in BAO patients within 6 hours of onset.  Despite a lack of definitive evidence, 
endovascular thrombectomy has been increasingly offered as a salvage operation based on promising 
results from case series.(3,4,6,7)  Despite advances in technique and recanalization rates as high as 90%, 
the majority of patients intervened upon still experience poor outcomes.  Previous studies have sought 
to determine which baseline characteristics are determinants of poor outcomes.  Characteristics 
associated with poor outcome have included age, higher stroke severity in clinical and imaging work-up, 
longer time to recanalization, and incomplete or failed recanalization.(4,5,8)  The current study is the 
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predictor of outcome following BAO.  Specifically, infarcts involving the brainstem portend a worse 
outcome. 
 
The relationship between final infarct volume and functional outcome has been established in the case 
of anterior circulation stroke.  Our group has previously reported that in a homogeneous group suffering 
middle cerebral artery occlusion (segment 1) treated with endovascular therapy, the most powerful 
predictors of outcome were age and final infarct volume.  From this we developed and validated a 
similar scoring system for outcome prediction in anterior circulation stroke (Pittsburgh Outcomes After 
Stroke Thrombectomy (POST)), based on patient age, final infarct volume, and presence of 
hemorrhage.(17)  
 
This current study supports a similar paradigm for outcome prediction in stroke secondary to BAO 
treated with endovascular therapy.  However, unique to BAO, these current results indicate that infarct 
location also plays a critical role in prediction.  Our findings are in keeping with previously published 
analyses evaluating brainstem stroke burden utilizing a semi-quantitative approach.  A scoring system 
based solely on brainstem infarct volume was utilized to predict presence and length of coma and 
outcome.(12,23)   In contrast, other analyses of post-procedural DWI lesion volume following BAO have 
failed to demonstrate a consistent correlation with outcome.  Possible reasons for this discrepancy 
include small sample size and the use of overall infarct volume alone, without accounting for 
pathoanatomic infarct distribution.(8)   
 
Prior series evaluating reversal of BAO have demonstrated that the time window during which 
reperfusion continues to be beneficial is longer than in anterior circulation strokes.(13)  A putative 
reason is that the brainstem may be more resistant to long-term ischemia than the cerebrum, including 
a more extensive network of collateral circulation and/or neuronal metabolism unique to the brainstem; 
which however remains unproven.(6)  Regardless of mechanism, this suggests that a subset of well 
selected patients may continue to benefit from recanalization even at late time points.8 
 
Our study has certain limitations.  First, this is a retrospective study without a predetermined imaging 
inclusion/exclusion protocol. Patients included in this study were treated across 4 high-volume stroke 
centers in both the US and Europe, and therefore represent a broad, multinational spectrum of patients 
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(44%), compared to mortality rates in the BEST (36%, p=0.19) and BASICS trials (41%, p=0.46), may be 
explained by longer time to treatment in our patients. Third, outcomes were only analyzed at 3 months, 
which may be too early of a time point to fully capture eventual neurological recovery.(14)  Fourth, the 
POST-VB score utilizes post-procedural scans, and therefore does not specifically address patient 
selection, but is instead limited to post-treatment prognostication.  Nevertheless, this scoring system 
has significant clinical utility for prognostication, as even those patients destined for good recovery may 
still have poor clinical exams early after treatment when important decisions guiding post-procedural 
care are being made.  Future studies will be necessary to address whether such information can be 
applied prior to continuation of intensive care to determine the likelihood of benefit.   
 
Conclusions 
This study demonstrates that the POST-VB scoring system can reliably predict outcome following acute 
reperfusion therapy for stroke due to BAO.   This scoring system cannot replace diligent patient 
evaluation and comprehensive assessment.  Nonetheless, the use of this grading system may help guide 
judicious patient selection for continued aggressive therapy following endovascular therapy and possibly 
decrease the risk inappropriately pursuing such care and avoid therapeutic futility.  Importantly, the 
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Table 1. Baseline Characteristics of Derivation Cohort (Center A, n=59) 
Age (mean, years) 64 ± 13 years 
Sex (male) 34% (20) 
NIHSS Score (median) 18 (IQR 22) 
Last known well to arrival (mean, hours) 13 (IQR 35) 
Vascular Risk Factors 
Hypertension 59% (35) 
Diabetes Mellitus 22% (13) 
Atrial Fibrillation 19% (11) 
Hypertriglyceridemia 39% (23) 
Coronary Artery Disease 22% (13) 
Smoking 22% (13) 
Intra-venous tPA 12% (7) 
Intra-arterial thrombolytics 42% (25) 
Endovascular thrombectomy  85% (50) 
TICI 2B or more 90% (53) 
mRS 0-2 at 90 days 32% (19) 





















Figure 1. Example of Volume Measurement by Infarct Location 
Figure 2. Median Infarct Volume by Location 
Figure 3. Receiver Operator Characteristic Curve for POST-VB Score at Different Sites 
ROC- Receiver Operator Characteristic 
 
Supplemental Material 
Figure S1. Modified Rankin Scale Score at 3 months 
Figure S2. Modified Rankin Scale Score at 90 days by binned POSTVB Score 
mRS-modified Rankin Scale Score 
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